Deracoxib-d3
Deracoxib-d3 (SC 046-d3; SC 59046-d3) is the deuterium labeled Deracoxib. Deracoxib, an orally active COX-2 inhibitor, is a veterinary nonsteroidal anti-inflammatory agent used exclusively in dogs. Deracoxib inhibits the COX-2 enzyme to reduce the production of prostaglandins, effectively controlling pain and inflammation after canine soft tissue surgery. Deracoxib reduces the inhibition of COX-1 and lowers the risk of gastrointestinal side effects. Deracoxib induces tumor cell cycle arrest and apoptosis, and shows anti-tumor activity in canine osteosarcoma, breast tumors and bladder transitional cell carcinomas.
Product Specifications
CAS Number
2012598-48-8
Product Name Alternative
SC 046-d3; SC 46-d3; SC 59046-d3
UNSPSC
12352005
Target
Apoptosis; COX; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Immunology/Inflammation; Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(N2N=C(C(F)F)C=C2C3=CC=C(OC([2H])([2H])[2H])C(F)=C3)C=C1)(N)=O
Molecular Formula
C17H11D3F3N3O3S
Molecular Weight
400.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8 (H1 + TS1), Biotin conjugate, 0.1mg/mL
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2391), CF594 conjugate, 0.1mg/mL
1-Fluoro-2,4-dinitrophenyl-5-L-alanine Amide-d3
S100A4 / Metastasin / Calvasculin (Marker of Tumor Metastasis) (rS100A4/1481), CF640R conjugate, 0.1mg/mL
